NCT06004661: Study of Lutetium (177Lu) Vipivotide Tetraxetan in mCRPC Participants With Moderately and Severely Impaired and With Normal Renal Function
- State
- Under way
- Phase
- Phase 2
- People
- 23 taking part
- Started
- 4 Apr 2024
- Primary completion
- 6 Nov 2026
- Arms
- AAA617
- Results
- None posted
- 22 Aug 2023: Trial registered
- 4 Apr 2024: Trial started